Therefore, our findings suggest that AAV‐mediated DNase I liver gene transfer might rebalance innate and adaptive immune response in the tumor microenvironment and restore immune control on cancer cells as one of the mechanisms inhibiting CRC metastasis development in the liver. Here, DNASE1 is linked to colorectal carcinoma.